Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed (2018 - 2025)

Eton Pharmaceuticals' Return on Capital Employed history spans 7 years, with the latest figure at 1.6% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 62.0% to 1.6% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.6%, a 62.0% increase, with the full-year FY2025 number at 2.1%, up 26.0% from a year prior.
  • Return on Capital Employed hit 1.6% in Q4 2025 for Eton Pharmaceuticals, down from 1.5% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ETON hit a ceiling of 39.49% in Q3 2023 and a floor of 56.76% in Q2 2022.
  • Historically, Return on Capital Employed has averaged 16.3% across 5 years, with a median of 7.2% in 2021.
  • Biggest five-year swings in Return on Capital Employed: surged 18434bps in 2021 and later crashed -8090bps in 2024.
  • Tracing ETON's Return on Capital Employed over 5 years: stood at 6.65% in 2021, then plummeted by -69bps to 11.26% in 2022, then surged by 31bps to 7.74% in 2023, then skyrocketed by 71bps to 2.22% in 2024, then rose by 28bps to 1.6% in 2025.
  • Business Quant data shows Return on Capital Employed for ETON at 1.6% in Q4 2025, 1.5% in Q3 2025, and 1.82% in Q2 2025.